© 2021 MJH Life Sciences and Cancer Network. All rights reserved.
© 2021 MJH Life Sciences™ and Cancer Network. All rights reserved.
January 04, 2021
Murphy discussed the secondary end point of equivocal findings on PSMA PET/CT from the proPSMA study presented at the SUO 21st Annual Meeting.
December 30, 2020
Declan Murphy, MB, BCh, shares his thoughts on the potential for prostate-specific membrane antigen PET/CT to impact outcomes for patients with localized and high-risk prostate cancers.
December 24, 2020
Declan Murphy discusses the accuracy findings from the proPSMA study presented at the 2020 SUO Meeting.
December 14, 2020
Declan Murphy discusses the motivation behind the proPSMA study and the emerging history of PSMA PET/CT to challenge conventional imaging at the 2020 SUO Meeting.
December 10, 2020
Declan Murphy talked about the future of PSMA theranostics to target metastatic castration-resistant prostate cancer.